Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Henry Schein, Inc.    HSIC

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Henry Schein : Zahn Dental Announces Agreement with Formlabs at LMT LAB DAY Chicago 2017

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/24/2017 | 04:03pm CET

Form 2, a Three-Dimensional Printer That Helps Enhance Digital Printing Capabilities for Laboratory Technicians, Now Available from Henry Schein's Lab Business

MELVILLE, N.Y., February 24, 2017 - Zahn Dental, Henry Schein, Inc.'s dental laboratory business, announced today at LMT LAB DAY Chicago 2017 a distribution agreement with Formlabs, designer and manufacturer of powerful and accessible three-dimensional (3D) printing systems. As part of the agreement, Zahn Dental will offer Formlabs's Form 2 desktop 3D printers and high-performance dental resins.

The printer, which uses Dental SG Resin - one of the first biocompatible resins in desktop 3D printing - offers laboratories an in-house solution that helps enhance the precision and accuracy of biocompatible surgical guides. In addition to surgical guides, Form 2 can be used for a variety of dental applications that can help improve patient outcomes of surgical procedures, such as orthodontic crown and bridge models, educational models, bleaching trays, retainers and aligners.

'Zahn's agreement with Formlabs underscores our commitment to providing customers with digital solutions they can rely on,' said Ken Haldeman, General Manager, Zahn Dental - U.S. 'Formlabs products have become indispensable tools for dental innovation. By continuing to offer innovative material and technology, we - together with our partners, including Formlabs - are helping drive the adoption of digital dentistry, which is powered by 3D printing.'

'We are very excited to be working with Zahn to offer this market-leading solution for laboratory technicians who are looking to push new boundaries in digital dentistry,' said Luke Winston, Head of Sales and Service at Formlabs.

To learn more about Form 2, please visit www.cap.com/formlabs or stop by Grand Ballrooms E, F at LAB DAY. Also at LAB DAY, Gideon Balloch, Dental Product Lead, Formlabs will participate in a #ScheinChat, a Henry Schein Facebook Live discussion, with Bob Cohen, Director of Product Development, Zahn Dental, on Saturday, February 25 at 9:00 a.m. CST, which can be viewed at Henry Schein Dental's Facebook page.

About Zahn Dental
Zahn Dental, the laboratory business of Henry Schein, is the largest distributor to dental laboratories in North America, and the world's largest distributor of removable prosthetic teeth and independent milling center. The business offers integrated solutions, cost-effective innovative products, breakthrough technologies and value-added services designed to enhance laboratory-management efficiency and profitability.

Zahn specialists, consultants and technicians are highly trained to help laboratories achieve professional goals with unique solutions. Zahn bridges the gap between dental practices and dental laboratories by leveraging the full-service ConnectDental® platform that helps laboratories communicate more seamlessly with clinicians who embrace digital impressions and other digital workflow.

About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the S&P 500® and Nasdaq 100® Indexes, Henry Schein employs more than 21,000 Team Schein Members and serves more than one million customers.

The company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items. The company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.

Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 33 countries. The company's sales reached a record $11.6 billion in 2016, and have grown at a compound annual rate of approximately 15 percent since Henry Schein became a public company in 1995. For more information, visit the Henry Schein website at www.henryschein.com.

About Formlabs
Formlabs designs and manufactures powerful and accessible 3D printing systems for engineers, designers, and artists. Their flagship product, the Form 2 3D printer, uses stereolithography (SLA) to create high-resolution physical objects from digital designs. The company was founded in 2012 by a team of engineers and designers from the MIT Media Lab and Center for Bits and Atoms.
With its powerful, intuitive, and affordable machines, Formlabs is establishing a new benchmark in professional desktop 3D printing. Formlabs also develops its own suite of high-performance materials for 3D printing, as well as best-in-class 3D printing software.

Henry Schein Inc. published this content on 24 February 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 24 February 2017 15:03:21 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HENRY SCHEIN, INC.
02/24 HENRY SCHEIN : Zahn Dental Announces Agreement with Formlabs at LMT LAB DAY Chic..
02/24 HENRY SCHEIN : Practice Solutions Announces Exclusive Distribution Agreement to ..
02/24 HENRY SCHEIN : Supported Study Demonstrates Link Between Poor Oral Health and Em..
02/23 HENRY SCHEIN : Launches TechCentral Hybrid Backup Service
02/23 HENRY SCHEIN : Launches Newly Designed Website For A Greater Customer Experience
02/22 HENRY SCHEIN : Medical Announces Exclusive Distribution Agreement For Rijuven's ..
02/21 HENRY SCHEIN : Management's Discussion and Analysis of Financial Condition and R..
02/21 HENRY SCHEIN : tops Street 4Q forecasts
02/21 HENRY SCHEIN, INC. (NASDAQ : HSIC) Files An 8-K Results of Operations and Financ..
02/21 HENRY SCHEIN INC : Results of Operations and Financial Condition, Financial Stat..
More news
Sector news : Medical Equipment Wholesale
02/21DJMEDTRONIC : Earnings Fall, Sales Rise -- Update
02/21 MEDTRONIC : sales, profit beat estimates; shares rise
02/21DJMEDTRONIC : Earnings Fall, Sales Rise
02/16 STRAUMANN : on hunt for 3D printer partner, could take stake - CEO
02/09 Smith & Nephew hurt by tough markets in China and Gulf states
More sector news : Medical Equipment Wholesale
News from SeekingAlpha
02/21 Henry Schein (HSIC) Q4 2016 Results - Earnings Call Transcript
02/21 Henry Schein, Inc. 2016 Q4 - Results - Earnings Call Slides
02/21 Henry Schein acquires Southern Anesthesia + Surgical
02/21 Henry Schein beats by $0.03, beats on revenue
02/20 Notable earnings before Tuesday?s open
Advertisement
Financials ($)
Sales 2017 12 071 M
EBIT 2017 876 M
Net income 2017 577 M
Debt 2017 680 M
Yield 2017 -
P/E ratio 2017 23,95
P/E ratio 2018 21,68
EV / Sales 2017 1,19x
EV / Sales 2018 1,13x
Capitalization 13 743 M
More Financials
Chart HENRY SCHEIN, INC.
Duration : Period :
Henry Schein, Inc. Technical Analysis Chart | HSIC | US8064071025 | 4-Traders
Full-screen chart
Technical analysis trends HENRY SCHEIN, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 179 $
Spread / Average Target 2,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stanley M. Bergman Chairman & Chief Executive Officer
James P. Breslawski President & Director
Steven Paladino Chief Financial Officer, Director & Executive VP
James A. Harding Chief Technology Officer & Senior Vice President
Philip A. Laskawy Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
HENRY SCHEIN, INC.13.32%13 743
COLOPLAST A/S4.14%14 014
PATTERSON COMPANIES, I..8.70%4 427
AMPLIFON SPA7.51%2 322
OWENS & MINOR, INC.2.13%2 214
SHIP HEALTHCARE HOLDIN..7.32%1 461
More Results